Fosun 复星’s Post

As the BIOSECURE Act draft legislation moves through Congress, multinational pharmaceutical companies are re-examining their R&D footprints and manufacturing supply chains. In a Nikkei Asia op-ed, TAG VPs Gopal Nadadur and Samuel Ide explain that India still has a ways to go in offering itself as a true alternative to China, but it could get there with new international investment, government’s initiatives, and support from like-minded partners. Read more here: https://lnkd.in/eGaby7D3

Today marks the 10th anniversary of Jiuzhou Pharma/九洲药业 Pharmaceutical's listing. Over the past decade, we have grown into a leading player in the #pharmaceutical industry while staying true to our mission: "Serve Life, Guard Health." 💯 Achievements Since our founding in 1973 and listing in 2014, we have established partnerships with over 900 pharmaceutical companies worldwide, becoming a top CDMO provider in China and earning numerous accolades. 💯 Social Responsibility We actively engage in philanthropic initiatives, supporting education and health projects while maintaining environmentally responsible practices in our production processes. 💯 Looking Ahead Jiuzhou Pharma/九洲药业 will continue to accelerate our internationalization efforts by establishing an overseas management headquarters in Singapore, a laboratory in Germany, and a wholly-owned subsidiary in Japan. These initiatives aim to better serve our global clients, enhance our R&D capabilities, and expedite the launch of #innovativedrugs. We look forward to leveraging these new platforms to further expand our international market presence and strengthen Jiuzhou's competitiveness in the global #pharmaceutical industry. 💌 Thank you to all our partners and clients for your support. Here’s to another decade of excellence at Jiuzhou Pharmaceutical! 📩 https://lnkd.in/eBsJwPVA #JiuzhouPharmaceutical #Innovation #Health #SustainableDevelopment #PharmaceuticalIndustry #CDMO

The estimated €50 billion investment in R&D by the pharmaceutical industry in Europe during 2023 underscores the region's commitment to innovation and health advancements. However, the rise of emerging economies like China and Korea presents a significant challenge. China's surpassing of Europe as the leading originator of new active substances highlights a shift in global research dynamics. To remain competitive, Europe must enhance its focus on fostering innovation, supporting research ecosystems, and creating favorable environments for pharmaceutical advancements. The urgency to adapt and innovate has never been greater. #WeWontRest#innovation#R&D#

Humanized Mouse and Rat Model Market Analysis, Emerging Trends, Growth Drivers, Opportunities, Challenges, and Leading Players: The Asia Pacific market is estimated to register the highest growth during the forecast period. Global pharmaceutical firms are increasingly moving to APAC to tap into its thriving market and lower their production costs by shifting manufacturing and laboratory testing … Continue reading → #HealthMedicine #PharmaceuticalsBiotech #UK #US #World

The secret to #Singapore’s world-class biopharma ecosystem is the willingness of different companies to collaborate and raise manufacturing productivity together. 🧬 At the Biopharmaceutical Manufacturer's Advisory Council (BMAC), industry leaders and government representatives regularly convene to discuss the factors that make for a robust ecosystem - from talent development and advancements in manufacturing technology to sustainability initiatives. 🌱 We had an engaging and insightful discussion at the 86th BMAC meeting, covering emerging trends and assessing how Singapore’s biomedical sector and local enterprises can continue to remain attractive to global players. Singapore’s biopharma industry contributed over S$19 billion in products to the global market in 2022 and we’ve welcomed multiple expansions in recent years, including best-in-class manufacturing facilities that push the boundaries on biologics and vaccines. 🧪 Let’s keep building on this momentum! 🚀 #bmac #biopharmaceuticals #Singapore #collaboration HockHeng Lim | Wong Chiak Wu | Andy Tjiawi Siong Wan Chan | Gerald Tang | Frank Walley | Ana Locatelli | Dan Hagewiesche | Tracy Lo | Liang Hong Koh | Selva G. | Paul Walshe | Pierre-Emmanuel Morin | Sridhar Dorai | Thirunavukkarasu, Ramasamy | Li Na Lee | Chong-Meng Chai 蔡崇铭 | George Lam | Wan Yee Goh | Pengfei Chen | Qiu Yi Loh | Kevin Lim | Dave Tan

Thought the health and pharmaceutical industry is all bland and boring? 🥱 You will be forgiven for having this perception, but think twice now, as innovative marketing in China has made pharma fun. 🎉 From what seemed rather odd messaging on ibuprofen, 💊 to a heartwarming touch on Gan Kang, ❤️ our friends in pharma have used their creativity to generate buzz around their products. There is no reason why other industries cannot do the same. 🚀 Read more: https://lnkd.in/g-SccuDq

Dr. Navil Prasad, Executive Director & CEO, Kirloskar Technologies Pvt Ltd, shares his insights on the evolving pharmaceutical supply chain at the ET Pharma Future-Ready Supply Chain Summit. With his extensive experience in the industry, Dr. Prasad explores key trends and technological advancements driving the future of supply chain management in pharma. His expert perspectives promise to inspire and guide leaders in adapting to an ever-changing landscape. Know more: https://bit.ly/3BkhWRf #ETPharmaSummit #FutureReadySupplyChain #SupplyChainExcellence #PharmaInnovation #FutureReadySupplyChain #PharmaLogistics #VectorConsultingGroup.

Hi everyone! 💊 Exciting developments are happening in the pharmaceutical sector across Europe and emerging markets today. 🚀 From innovative research to cutting-edge technologies, the industry is booming with new product development. 🌟 I'm thrilled to share insights on how countries like the UK, Germany, and Switzerland are paving the way with their advanced manufacturing processes within the pharmaceutical sector. 🇬🇧🇩🇪🇨🇭 Meanwhile, emerging markets such as Poland, Czech Republic, and Hungary are also making significant strides in developing new and groundbreaking products. 🌍 The dedication to quality and innovation in these regions is truly inspiring, shaping the future of healthcare worldwide. 💡 Let's continue to champion progress and excellence in pharmaceutical manufacturing together! 🌐 #PharmaInnovation #EuropeManufacturing #EmergingMarketsSuccess 🌿

"India: A Trailblazer in Global Sourcing" – Yugal Sikri, Managing Director of RPG Life Sciences Ltd., takes the stage at the ET Pharma Future-Ready Supply Chain Summit to share valuable insights into India's evolving role as a leader in global sourcing. As global supply chains adapt to new challenges, India’s strategic position as a sourcing hub is becoming increasingly important. Mr. Sikri’s session highlights innovative approaches and key trends shaping the future of pharmaceutical sourcing. Know more: https://bit.ly/3BkhWRf #ETPharmaSummit #FutureReadySupplyChain #SupplyChainExcellence #PharmaInnovation #FutureReadySupplyChain #PharmaLogistics #VectorConsultingGroup.

The China Study Tour offered us an incredible learning experience with former eTradeforWomen Advocate, Ms. Xiaofei Yao, Founder of Rogrand, China's leading pharmaceutical platform. Ms Xiaofei shared powerful insights into her journey as a business leader, showing how she has used #technology and innovation to transform the pharmaceutical industry. Her experiences provided valuable lessons on building a thriving #digital #business and overcoming challenges along the way. One thought that really resonated with me was when Ms Xiaofei said, "As the founder, I am the dreamer. I choose who I want beside me to achieve my dream." Ms Xiaofei’s words remind us all of the power we have as leaders and dreamers to shape our own path and surround ourselves with those who believe in our vision. Building a successful business isn’t just about strategy and innovation; it’s about creating a team that shares your passion and purpose. Dreams are meant to be bold, and with the right people by our side, there’s no limit to what we can achieve. #Entrepreneurship #Innovation #DigitalTransformation #WomenInBusiness #TechForGood #recqa #womencommunity #womenempowerment